Verification of performance specifications for a US food and drug administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assay

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 1, 2012, Pages 20-25

  Schlaberg, Robert ^a,d   Mitchell, Michael J ^b   Taggart, Edward W ^a   She, Rosemary C ^c  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Southern California Permanente Regional Reference Laboratories   (United States)

^d ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ARTICLE; CHEMISTRY; CLOSTRIDIUM DIFFICILE; FECES; FOOD AND DRUG ADMINISTRATION; GENETICS; HUMAN; INSTRUMENTATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; PSEUDOMEMBRANOUS COLITIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED STATES;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84856028772     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0138-OA     Document Type: Article

References (14)

1. Borst A, Box AT, Fluit AC. False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis. 2004;23(4):289-299. (Pubitemid 38669939)
2. Jennings L, Van Deerlin VM, Gulley ML. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med. 2009;133(5):743-755.
3. Clark RB, Lewinski MA, Loeffelholz MJ, Tibbetts RJ. Cumitech 31A: Verification and Validation of Procedures in the Clinical Microbiology Laboratory. Washington, DC: American Society of Microbiology; 2009.
4. Clinical and Laboratory Standards Institute. Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2006. CLSI document MM3-A2.
5. National Committee for Clinical Laboratory Standards. User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2002. NCCLS document EP 12-A.
6. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008;359(18):1932-1940.
7. BD Diagnostics. BD GeneOhmTM Cdiff Assay, 510(k) SUMMARY. http://www.accessdata.fda.gov/cdrh-docs/pdf8/K081920.pdf. Accessed March 26, 2011.
8. Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol. 2009;47(4):1276-1277.
9. Stamper PD, Alcabasa R, Aird D, et al. Comparison of a commercial realtime PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47(2):373-378.
10. BD Diagnostics. BD GeneOhmTM Cdiff Assay, Package insert. http://www.bd.com/geneohm/english/products/pdfs/cdiff-pkginsert.pdf. Accessed March 26, 2011.
11. Peterson LR, Manson RU, Paule SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis. 2007;45(9): 1152-1160. (Pubitemid 47580313)
12. Clinical and Laboratory Standards Institute. User Verification of Performance for Precision and Trueness; Approved Guideline. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2005. CLSI document EP 15-A2.
13. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.
14. Federal Register. Subpart M-Personnel for Moderate Complexity, Including the Subcategory and High Complexity Testing. Source: 57 FR 7172. http://wwwn.cdc.gov/clia/regs/subpart-m.aspx. Accessed March 26, 2011.